Related references
Note: Only part of the references are listed.Profound consequences of hidradenitis suppurativa: a review
L. Matusiak
BRITISH JOURNAL OF DERMATOLOGY (2020)
Investigational drugs in clinical trials for Hidradenitis Suppurativa
Peter Theut Riis et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2018)
Successful Treatment of Severe Recalcitrant Hidradenitis Suppurativa with the Interleukin-17A Antibody Secukinumab
Anna Schuch et al.
ACTA DERMATO-VENEREOLOGICA (2018)
Clinical Characteristics of Pruritus and Pain in Patients with Hidradenitis Suppurativa
Lukasz Matusiak et al.
ACTA DERMATO-VENEREOLOGICA (2018)
Complement activation in hidradenitis suppurativa: a new pathway of pathogenesis?
T. Kanni et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Effects of adalimumab on T-helper-17 lymphocyte- and neutrophil-related inflammatory serum markers in patients with moderate-to-severe hidradenitis suppurativa
D. Jimenez-Gallo et al.
CYTOKINE (2018)
Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: Implications for treatment with anti-IL-17 agents
Lukasz Matusiak et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Observational case series on adalimumab-induced paradoxical hidradenitis suppurativa
Marine Delobeau et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2016)
Ustekinumab, another biologic with potential to help patients with hidradenitis suppurativa?
D. B. Eisen
BRITISH JOURNAL OF DERMATOLOGY (2016)
Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum
J. L. Blok et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Adalimumab for the treatment of hidradenitis suppurativa/acne inversa
Christos C. Zouboulis
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2016)
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
Alexa B. Kimball et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa A Randomized Clinical Trial
Vassiliki Tzanetakou et al.
JAMA DERMATOLOGY (2016)
Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa
Christina Fotiadou et al.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2016)
Two cases of severe hidradenitis suppurativa with failure of anakinra therapy
D. Menis et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa
Alex Anstey
BRITISH JOURNAL OF DERMATOLOGY (2015)
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
C. C. Zouboulis et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Use of biological treatments in patients with hidradenitis suppurativa
G. Martin-Ezquerra et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Moderate to severe hidradenitis suppurativa treated with biological therapies
Niranthari Chinniah et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2014)
The prevalence of hidradenitis suppurativa in 1093 patients with inflammatory bowel disease
H. H. van der Zee et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
Four-weekly infliximab in the treatment of severe hidradenitis suppurativa
B. Moriarty et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
Management of Hidradenitis Suppurativa with Biological Therapy: Report of Four Cases and Review of the Literature
Constanza Bahillo Monne et al.
DERMATOLOGY (2014)
An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa
Kieron S. Leslie et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Ustekinumab for Hidradenitis Suppurativa: A Case Report
M. I. Santos-Perez et al.
ACTAS DERMO-SIFILIOGRAFICAS (2014)
Tumour Necrosis Factor-alpha and Matrix Metalloproteinase-2 are Expressed Strongly in Hidradenitis Suppurativa
Elga Mozeika et al.
ACTA DERMATO-VENEREOLOGICA (2013)
Successful long-term triple disease control by ustekinumab in a patient with Behcet's disease, psoriasis and hidradenitis suppurativa
Ewout M. Baerveldt et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Failure of Anti-Interleukin-1 Therapy in Severe Hidradenitis Suppurativa: A Case Report
H. H. van der Zee et al.
DERMATOLOGY (2013)
Adalimumab in Treatment-Resistant Hidradenitis Suppurativa following Recurrence after Extensive Affected Area Excision: A Review of Biologics Therapy
Michael Samycia et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2013)
Incidence of Hidradenitis Suppurativa and Associated Factors: A Population-Based Study of Olmsted County, Minnesota
Benjamin G. Vazquez et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Treating inflammation by blocking interleukin-1 in humans
Charles A. Dinarello et al.
SEMINARS IN IMMUNOLOGY (2013)
Successful Treatment of Severe Hidradenitis Suppurativa With Anakinra
Kian Zarchi et al.
JAMA DERMATOLOGY (2013)
Management of Recalcitrant Hidradenitis Suppurativa with Ustekinumab
Victoria R. Sharon et al.
ACTA DERMATO-VENEREOLOGICA (2012)
Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa A Parallel Randomized Trial
Alexa B. Kimball et al.
ANNALS OF INTERNAL MEDICINE (2012)
Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study
H. H. van der Zee et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Treatment of severe hidradenitis suppurativa with infliximab in combination with surgical interventions
D. C. van Rappard et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Association and management of Crohn's disease plus hidradenitis suppurativa
Carlos Henrique Marques dos Santos et al.
INFLAMMATORY BOWEL DISEASES (2012)
Acne inversa successfully treated with infliximab
Anna Catharina Prinzessin von Preussen et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2012)
Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa
Dominique C. van Rappard et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2012)
Long-term efficacy of infliximab in hidradenitis suppurativa
Sabela Paradela et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2012)
Experience with ustekinumab for the treatment of moderate to severe Hidradenitis suppurativa
W. P. Gulliver et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2012)
Hidradenitis Suppurativa
Gregor B. E. Jemec
NEW ENGLAND JOURNAL OF MEDICINE (2012)
An Overview of Interleukin-1 Receptor Antagonist, Anakinra, in the Treatment of Cutaneous Diseases
Nader Pazyar et al.
CURRENT CLINICAL PHARMACOLOGY (2012)
Efficacy of Infliximab for Hidradenitis Suppurativa: Assessment of Clinical and Biological Inflammatory Markers
Maia Delage et al.
ACTA DERMATO-VENEREOLOGICA (2011)
Severe Hidradenitis Suppurative in an HIV-Positive Male: Use of Multiple Treatment Modalities, Including Tumor Necrosis Factor Blockade
Husein Husein-ElAhmed et al.
AIDS PATIENT CARE AND STDS (2011)
New-onset polyarthritis during successful treatment of hidradenitis suppurativa with infliximab
D. C. van Rappard et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa
I. Miller et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β
H. H. van der Zee et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa
Christoph Schlapbach et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Discovery and mechanism of ustekinumab A human monoclonal antibody targeting interleukin-12 and interleukin-23 for treatment of immune-mediated disorders
Jacqueline M. Benson et al.
MABS (2011)
A Case of Hidradenitis Suppurativa Refractory to Anti-TNF alpha Therapy in a Patient With Crohn's Disease
Stavroula Koilakou et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Treatment of Hidradenitis Suppurativa with Infliximab
Tiago Torres et al.
ANAIS BRASILEIROS DE DERMATOLOGIA (2010)
Severe Refractory Hidradenitis Suppurativa in an HIV-Positive Patient Successfully Treated With Infliximab
Diana Alecsandru et al.
ARCHIVES OF DERMATOLOGY (2010)
Treatment of Hidradenitis Suppurativa With Etanercept Injection
David R. Adams et al.
ARCHIVES OF DERMATOLOGY (2010)
Hidradenitis suppurativa responding to treatment with infliximab
Anita Lasocki et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2010)
Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study
H. H. van der Zee et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Interstitial Keratitis Secondary to Severe Hidradenitis Suppurativa: A Case Report and Literature Review
Ana G. Alzaga Fernandez et al.
CORNEA (2010)
Long-term efficacy of etanercept in hidradenitis suppurativa: results from an open-label phase II prospective trial
Aimilia Pelekanou et al.
EXPERIMENTAL DERMATOLOGY (2010)
A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativa
Masahiro Amano et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2010)
Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy
Monika Arenbergerova et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2010)
Infliximab therapy for patients with moderate to severe hidradenitis, suppurativa: A randomized, double-blind, placebo-controlled crossover trial
Annika Grant et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Hidradenitis suppurativa markedly decreases quality of life and professional activity
Lukasz Matusiak et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Pyoderma Gangrenosum Associated with Hidradentitis Suppurativa: A Case Report and Review of the Literature
A. E. Garcia-Rabasco et al.
ACTAS DERMO-SIFILIOGRAFICAS (2010)
Etanercept for the Treatment of Hidradenitis Suppurativa
Eleni Sotiriou et al.
ACTA DERMATO-VENEREOLOGICA (2009)
Increased Serum Tumour Necrosis Factor-alpha in Hidradenitis Suppurativa Patients: Is There a Basis for Treatment with Anti-Tumour Necrosis Factor-alpha Agents?
Lukasz Matusiak et al.
ACTA DERMATO-VENEREOLOGICA (2009)
Hidradenitis suppurativa treated with infliximab
Daniel Lago Obadia et al.
ANAIS BRASILEIROS DE DERMATOLOGIA (2009)
Long-term Successful Adalimumab Therapy in Severe Hidradenitis Suppurativa
Ricardo Blanco et al.
ARCHIVES OF DERMATOLOGY (2009)
Long-term Course of Demyelinating Neuropathies Occurring During Tumor Necrosis Factor-α–Blocker Therapy
Pierre Lozeron et al.
ARCHIVES OF NEUROLOGY (2009)
Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity
K. Sartorius et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Successful Treatment of Hidradenitis Suppurativa with Infliximab in a Patient Who Failed to Respond to Etanercept
Yves Poulin
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2009)
A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa
Robert A. Lee et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Hidradenitis suppurativa
J. Revuz
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
Hidradenitis suppurativa:: are tumour necrosis factor-α blockers the ultimate alternative?
A. M. G. Brunasso et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Amyloidosis secondary to hidradenitis suppurativa. Exceptional response to infliximab
J.A. Montes-Romero et al.
European Journal of Internal Medicine (2008)
Bilateral Candida chorioretinitis following etanercept treatment for hidradenitis suppurativa
P. Arriola-Villalobos et al.
EYE (2008)
Efficacy of Infliximab treatment in patients with severe Fistulizing Hidradenitis Suppurativa
Margarita Elkjaer et al.
JOURNAL OF CROHNS & COLITIS (2008)
Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies
Jean E. Revuz et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Pachyonychia congenita and hidradenitis suppurativa: no response to infliximab therapy
J. Pedraz et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2008)
Long-term efficacy of etanercept in hidradenitis suppurativa
A. Zangrilli et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2008)
An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa
E. J. Giamarellos-Bourboulis et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Long-term efficacy of a single course of infliximab in hidradenitis suppurativa
J. R. Mekkes et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases
Samuel L. Moschella
INTERNATIONAL JOURNAL OF DERMATOLOGY (2007)
HIDRADENITIS SUPPURATIVA. RESPONSE TO TREATMENT WITH INFLIXIMAB
J. Pedraz et al.
ACTAS DERMO-SIFILIOGRAFICAS (2007)
Infliximab for severe hidradenitis suppurativa: Transient clinical efficacy in 7 consecutive patients
Laurence Fardet et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Quality of life impairment in hidradenitis suppurativa: A study of 61 cases
Pierre Wolkenstein et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Infliximab for the treatment of hidradenitis suppurativa
J. M. Fernandez-Vozmediano et al.
DERMATOLOGY (2007)
Long-term infliximab for severe hidradenitis suppurativa
A. -M. Thielen et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Severe hidradenitis suppurativa treated with adalimumab
Danielle K. Moul et al.
ARCHIVES OF DERMATOLOGY (2006)
Treatment of coincident seronegative arthritis and hidradentis supprativa with adalimumab
N Scheinfeld
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease
YL Rosi et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2005)
Severe hidradenitis Suppurativa treated with infliximab infusion
DR Adams et al.
ARCHIVES OF DERMATOLOGY (2003)
Hidradenitis suppurativa associated with Crohn's disease and spondyloarthropathy: response to anti-TNF therapy
M Roussomoustakaki et al.
JOURNAL OF GASTROENTEROLOGY (2003)
Infliximab for hidradenitis suppurativa
TP Sullivan et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
Hidradenitis suppurativa and Crohn's disease:: Response to treatment with infliximab
F Martínez et al.
INFLAMMATORY BOWEL DISEASES (2001)
Share Paper
